Clinical Trial Title
Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients with Ischemic Cardiomyopathy (AIM-VT) – A Prospective Single-Blinded, Multicenter Randomized Controlled TrialNational Clinical Trial Number:
NCT06138873Contact Information
Clinical Trial Protocol Description:
Prospective multicenter randomized controlled trial (RCT) investigating whether Ablation Index-guided ventricular tachycardia (VT) ablation improves procedural efficiency, therapeutic efficacy, and safety in comparison to VT ablation guided by conventional strategies in patients with ischemic cardiomyopathy and with VT.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Are at least 18 years of age.
- Have a history of coronary artery disease and ischemic cardiomyopathy.
- Have sustained ventricular tachycardia documented by ECG or interrogation of your ICD device.
This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.
Study Details
Clinical Trial Investigator
Henry D. Huang
Contact Information
Henry Darchon Huang
Clinical Trial Location
Rush University Medical Center